Seattle – September 13, 2021 – AGC Biologics today announced expansion plans for the company’s Heidelberg facility to increase manufacturing capacities for plasmid-DNA (pDNA) and messenger RNA (mRNA) projects.
AGC Biologics Expands pDNA and mRNA Manufacturing Capacity
Nick McDonald Published on 9/13/21 5:00 PM News
Learn More
Follow Us
